Dosage & Administration:
For Severe Renal Impairment: No dose adjustment is needed for mild or moderate renal impairment (CrCl> 30 mL/min). For patients with severe renal impairment (CrCl ≥ 15 to < 30 mL/min) the recommended dose of Betrixaban is an initial single dose of 80 mg followed by 40 mg once daily.
For Hepatic Impairment: No dose adjustment is required in patients with mild hepatic impairment. Avoid use in patients with moderate to severe hepatic impairment.
BetriXa™ 80 Capsule: Each box contains 10 capsules in blister pack.